Consensus from Controversy: Cambridge's Biosafety Ordinance and the Anchoring of the Biotech Industry

Maryann Feldman and Nichola Lowe

European Planning Studies, 2008, vol. 16, issue 3, 395-410

Abstract: This paper provides an interpretative history of the early genesis of biotechnology in Cambridge and attempts to reconcile how the 1976 adoption of the most restrictive biosafety ordinance in the US created an unexpected business friendly environment that subsequently anchored the industry. The regulation was motivated by community concerns about the environmental effects of recombinant DNA and ignited a lively debate, characterized by an open process with activities to inform and involve citizens in decision-making.

Date: 2008
References: View complete reference list from CitEc
Citations: View citations in EconPapers (3)

Downloads: (external link)
http://hdl.handle.net/10.1080/09654310801920532 (text/html)
Access to full text is restricted to subscribers.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:taf:eurpls:v:16:y:2008:i:3:p:395-410

Ordering information: This journal article can be ordered from
http://www.tandfonline.com/pricing/journal/CEPS20

DOI: 10.1080/09654310801920532

Access Statistics for this article

European Planning Studies is currently edited by Philip Cooke and Louis Albrechts

More articles in European Planning Studies from Taylor & Francis Journals
Bibliographic data for series maintained by Chris Longhurst ().